Clinical Trial

CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.

Study acronym: CLAARITY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
CLAARITY is a prospective, observational, single-arm, multi-center, post-market US study designed to evaluate the safety and performance of the ECLIPTIS clip in a minimum of 168 participants.
Trial Details
NCT Number NCT07742839
Lead Sponsor Edwards Lifesciences
Conditions Atrial Appendage
Enrollment 168 participants
Start Date 2026-09-30
Primary Completion 2027-07-10 (estimated)
Study Completion 2030-08-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-03